![number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely F/31/5'3 [220 > 140] gymnema Size:30 Capsules](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1254832130187487)
![number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely F/31/5'3 [220 > 140] gymnema Size:30 Capsules](https://i.abcnewsfe.com/a/69f8c5f1-8561-4558-94b0-a782506c7010/ozempic-mounjaro-1-gty-bb-240709_1720530741361_hpMain_16x9.jpg?w=1600)
![number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely F/31/5'3 [220 > 140] gymnema Size:30 Capsules](https://i.ytimg.com/vi/cJxZ0_2bJek/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLBnIKgBvCvDU9L6vOwUmfdXEkWJSA)
![number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely F/31/5'3 [220 > 140] gymnema Size:30 Capsules](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3867898126778062098)
USD21.57
USD61.57
Pay in 4 interest-free payments of $5.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
